1 |
Abe K., Nakada Y, Suzuki A. and Yumioka E. Biliary metabolites of hesperetin in rats. Shoyakugaku Zasshi, 47, 43-46 (1993)
|
2 |
Bae E.-A., Han M. J., Choo M.-K., Park S.-Y. and Kim D.-H. Metabolism of 20(5)- and 20CR)-ginsenoside Rg3 by human intestinal bacteria and its reladon to in vitro biological acdvides. Biol. Pharm. Bull., 24,58-63 (2002)
|
3 |
Booth A. N., Jones F. T. and DeEds P. Metabolic fate of hespendin, eriodictyol, homoeriodictyol and diosmin. J. Biochem. Chem., 230, 661-668 (1958)
|
4 |
Griffths L. A. Studies on metabolism of flavonoids. Biochem. J.,92, 173-175 (1964)
DOI
|
5 |
Hattori M., Sakamoto, T., Kobashi K., and Namba T. Metabolism of glycrrhizin by human intestinal bacteria. Ptanta Med., 48, 38-42 (1983)
DOI
ScienceOn
|
6 |
Kobashi K. and Akao T. Relation of intestinal bacteria to phannacological effects of glycosides. Bifidobacteria Micmflora, 16, 1-7 (1997)
|
7 |
Kumagai A., yano S., Otome M. and Takeuchi K. Study on the corticoid-like action of glycyrrhizinic and the mechanism of its action. Endocrinol Jpn., 4, 12-27 (1957)
DOI
ScienceOn
|
8 |
Lee K. T., Sohn I. C., Park H. J., Kim D. W., Jung K. O. and Park K. Y. Essential moiety for antimutagenic and cytotoxic activity of hederagenin monodesmosides and bisdesmosides isolated from the stem bark of Kalopanax pictus. Planta Med., 66, 329-332 (2000)
DOI
ScienceOn
|
9 |
Lee M. and Hahn D. R. Triterpenoidal saponins from the leaves of Kalopanax pictum var. chinense. Arch. Pharm. Res., 14, 124-128 (1991)
DOI
ScienceOn
|
10 |
Sano K., Sanada S., Ida, Y. and Shoji J. Studies on the constituents of the stem bark of Katopanax pictus. Chem. Pharm. Bull., 39, 865-870 (1991)
DOI
|
11 |
Shim S. B., Kim N. J. and Kim D. H. Glucuromdase inhibitory activity and hepatoprotecdve effect of 18-g1ycyrrhetimc acid from the rhizomes of Glycyrrhiza uralensis. Ptanta Med., 65, 40-43 (2000)
|
12 |
Tamura G., Gold C., Ferro-Luzzi A. and Ames B. N. Fecalase-A model for activation of dietary glycosides to mutagens by intestinal flora. Proc. Natl. Acad. Sci. in USA, 77, 4981-4965 (1980)
|
13 |
Wu J. Y, Gardner B. H., Murphy C. I., Seals J. R., Kensil C. R., Recchia J., Beltz G. A., Newman G. W. and Newman M. J. Saponin adjuvant enhancement of antigen-specific immune responses to an experimental HFV-l vaccine. J. Immunol., 148, 1519-1525 (1992)
PUBMED
|
14 |
Shao C. J., Kasai R., Xu J. D. and Tanaka O. Saponms from roots of Kahpanax septemlobus (Thunb.) Koidz., Ciqiu: Structures of kalopanaxsaponins C, D, E and F. Chem. Pharm. Bull., 37, 311-314(1989)
DOI
|
15 |
Finney R. S. H. and Somers G. F. The and-inflammatory activity of glycyrretimc acid and derivadves. J. Pharm. Pharmacol 10,613-620 (1958)
DOI
|
16 |
Pompeo R., Flore O., Marccialis M. A., Pani A.,and Loddo B. Glycyrrhizic acid inhibits virus growth and inacdvates virus partices. Nature, 281, 689-690 (1979)
DOI
ScienceOn
|
17 |
Griffith L.A. and Smith G.E. Metabolism of myricetin and related compounds in the rat metabolite formadon in vivo and by the intestinal microflora in vitro. Biochem. J., 130, 141-151 (1972)
DOI
|
18 |
Mochizuki M., Yoo Y. C., Matsuzawa K., Sato K., Saiki I., Tono-oka S., Samukawa K. and Azuma I.1nhibitory effect of tumor metastasis in mice by saponins, ginsenoside-RbZ, 20(R)- and 20(S)-ginsenoside-Rg3, of red ginseng. Biol. Pharm. Bull., 18, 1197-1202(1995)
DOI
PUBMED
ScienceOn
|
19 |
Tangri K.K., Seth P. K., Parmar S. S. and Bhargava K. P. Biochemical study of anti-inflammatory and antiarthhdc properties ofglycynedc acid. Biochem. Pharmacol., 14, 1277-1281 (1965)
DOI
ScienceOn
|
20 |
Kim D. H., Jung E. A., Sohng I. S., Han J. A., Kim T. H. and Han M. J. Intestinal bacterial metabolism of flavonoids and its relation to some biological activities. Arch, Pharm. Res., 21, 17-23 (1998)
DOI
|
21 |
Bae E. A., Choo M. K., Park E. K., Park S. Y, Shinn H. Y. and Kim D. H. Metabolism of gmsenoside Rc by human intesdnal bacteiia and its related antiallergic activity. In press
|
22 |
Han B. H., Park M. H., Han, Y. N., Woo W. S., Sankawa U., Yahara S., and Tanaka O., Degradadon of ginseng saponins under mild acidic condidons. Planta Med., 44, 146-149 (1982)
DOI
PUBMED
ScienceOn
|
23 |
Sato K., Mochizuki M., Saiki I., Yoo Y. C. Samukawa K. and Azuma I.Inhibition of tumor angiogenesis and metastasis by a saponin of Panax ginseng, ginsenoside-Rb2. Biot. Pharm. Bull., 17, 635-639 (1994)
DOI
ScienceOn
|
24 |
Akao T., Akao T. and Kobashi K. Glycyrrhizm glucuronidase of Eubacterium sp. from human intestinal flora. Chem. Pharm. Bull 35, 705-710 (1987)
DOI
PUBMED
ScienceOn
|
25 |
Bokkenheuser V. D., Shackleton H. L. and Winter J. Hydrolysis of dietary Qavonoid glycosides by strains of intestinal Bacteroides from humans. Biochem. J., 248, 953-957 (1987)
DOI
PUBMED
|
26 |
Hasegawa H., Sung J.-H., Matsumiya, S. and Uchiyama M., Main gmseng saponin metabolites formed by intestinal bacteria. Ptanta Med., 62, 453-457 (1996)
DOI
ScienceOn
|
27 |
Bjeldans L. N. and Chang G. W. Mutagenic acdvity of quercetin and related compoungs. Science, 197, 577-578 (1997)
|
28 |
Kim D.-H., Yu K.W., Bae E.A., Park H.J. and Choi J.W. Metabolism of kalopanaxsaponin B an H by human intestinal bacteria and anddiabetic activity of their metabolites. Biol. Pharm. Bull, 21, 360-365 (1998)
DOI
PUBMED
ScienceOn
|
29 |
Lee S.J., Sung J. H., Lee S. J., Moon C. K. and Lee B. H. Antitumor activity of a novel ginseng saponin metabolite in human pulmonary adenocarcinoma cells resistant to cisplatin. Cancer Lett., 144, 39-43 (1999)
DOI
ScienceOn
|
30 |
Park H. J., Kim D. H., Choi J. W., Park J. H., and Han Y. N., A potent anti-diabetic agent from Kalopanax pitus. Arch. Pharm. Res., 21, 24-29 (1998)
DOI
PUBMED
|
31 |
Brown J. P. A Review of the genetis effects of naturally occurring flavonoids, anthraquinones and related compounds, Mutat. Res., 75, 243-277 (1980)
DOI
PUBMED
ScienceOn
|
32 |
Park H. J., Kwon S. K., Lee J. H., Lee K. K., Miyamoto K., and Lee K. T., Kalopanaxsaponin A is a basic saponin structure for the antitumor activity of hederagenin monodesmosides. Planta Med.,67, 118-121 (2001)
DOI
ScienceOn
|
33 |
Nakagawa Y, Shetler M. R. and Wender S. H. Uiinary products from quercetin in neomycin-treated rats. Biochim. Biophys. Acta, 97, 233-241 (1965)
DOI
ScienceOn
|
34 |
Conn J.W., Rovner D.R. and Cohen E.L. Licorice induced pseudoaldosteronism, hypertentsion, hypolalemia, aldosteronopenia and supressed plasma renin acdvity. J. Am. Med. Ass., 205, 80-84 (1968)
|
35 |
Das N. P. Studies on flavonoid metabolism. Degradation of (+)-catechin by rat mtestinal contents. Biochim. Biophys. Acta, 177,668-670 (1969)
|
36 |
Park H. J., Lee K. T., Jung W. T., Choi J. W., and Kadota S., Protective effects of syringin isolated from Kalopanax pictus on galactosamine induced hepatotoxicity. Nat. Med., 53, 113-117(1999)
|
37 |
Griffiths L. A. and Smith G. E. Metabolism of apigenin and related compounds in the rats. Biochem. J., 128, 901-911 (1972)
DOI
PUBMED
|
38 |
Kim D. H., Jang I. S., Lee H. K. Jung E. A. and Lee K. Y. Metabolism of glycyrrhizin and baicalin by human intestinal bacteria. Arch. Pharm. Res., 19, 292-296 (1996)
DOI
ScienceOn
|
39 |
Pamukcu A. M. Quercetin, a rat intestinal and bladder carcinogen present in Bracken Fern. Cancer Res., 40, 3468-3472 (1980)
PUBMED
|
40 |
Kwon S. W., Han S. B., Park I. H., Kim J. M., Park M. K. and Park J. H. Liquid chromatographic determination of less polar ginsenosides in processed ginseng. J. Chromatogr., 921, 335-339 (2001)
DOI
ScienceOn
|
41 |
MacGregor J. R. Mutagenicity studies of flavonols in vivo and in vitro. Toxic. Appl. Pharm., 48, A47 (1979)
|
42 |
Kim D. H., Jang I. S., Kim N. J. and Youn W. K. Metabolism of poncirin and naringin by human intestinal bacteria. Yakhak Hoeji, 38, 286-292 (1994)
|
43 |
Krishnamurty H. G., Cheng K. J., Simpson F. J. and Watkin J. E. Identification of products produced by the anaerobic degradation of rutin and related flavonoids by Butyrivibrio. C3. Can. J. Microbiol., 16, 759-767 (1970)
|
44 |
Abe N., Ebina T. and Ishida N. Interferon inducdon by glycyrrhizin and glycyrretinic acid in mice. Microbiol Immunol., 26, 535-539 (1982)
DOI
PUBMED
|
45 |
Akao T., Kida H., Kanaoka M., Hattori M. and Kobashi K. Intestinal bacterial hydrolysis is required for the appearance of compound K in rat plasma after oral adrninistration of ginsenoside Rbl from Panax ginseng. J. Pharm. Pharmacol., 50,1155-1160(1998)
DOI
ScienceOn
|
46 |
Kanaoka M., Akao T. and Kobashi K. Appearance of compound K, a major metabolite of ginsenoside Rbl by intestinal bacteria, in rat plasma after oral administration-measurement of compound K by enzyme immunoassay. Biol. Pharm. Bull., 21, 245-249 (1998)
DOI
ScienceOn
|
47 |
Kim D. H., Jang I. S. and Lee S. W. Bacteorides J-37, a human intestinal bacterium, Produces glucuronidase. Biol. Pharm. Bull., 20, 834-837 (1997)
DOI
PUBMED
ScienceOn
|
48 |
Kim D. W., Bang K. H., Rhee Y. H., Lee K. T, and Park H. J. Growth inhibitory acdvides of kalopanaxsaponins A and I against human pathogenic fungi. Arch. Pharm. Res., 21, 688-91 (1998)
DOI
ScienceOn
|
49 |
Stoewsand G. S., Anderson J. L., Boyd J. N. and Harzdine G. Ouercetin: A Mutagen not a carcinogen in fischer rats. J. Toxic. Environ. Health. 14, 105-114 (1984)
DOI
ScienceOn
|
50 |
Cheng K. J., Krishnamurty H. G., Jones G. A. and Simpson F. J. Identificadon of products produced by the anaerobic degradadon of nanngin by Butyrivibrio sp. C3. Can. J. Micmbiol., 17, 129-131 (1971)
|
51 |
Fujita H., Sakurai T. and Toyoshima S. Studies on the regulation by drugs against expehmental hepatitis (1) The therapeudcal effects of glycyrrhizinic acid, DL-methionine, their complex and tablets against acute injuly induced by carbon tetrachloride or D-galactosamine. Oyo Yakuri, 16,637-645 (1978) (m japanese)
|
52 |
Petrakis P. L., Kallianos A. G.. Wender S. H. and Sheltar M. R. Metabolic stidies of quercitin labled with . Arch. Biochem. Biophys., 85, 264-271 (1959)
DOI
PUBMED
ScienceOn
|
53 |
Kariloira M., Miyaze T., Tanizawa H., Taniyama T. and Takino Y. Studies on absorption, distribution, excredon and metabolism of ginseng saponins. VII. Compahson of the decomposition modes of ginsenoside-Rbl and -Rb2 in the digestive tract of rats. Chem. Pharm. Bull., 38, 2357-2361 (1991)
|
54 |
Wakabayashi C., Hasegawa H., Murata J. and Saiki I. In vivo antimetastatic action of emsene protopanaxadiol saponins is based on their intestinal bacterial metabolites after oral administration. Onwl. Res., 9, 411-417 (1998)
|
55 |
Akao T., Akao T., Hatdon M., Kanaoka M., Yamamoto K., Namba T. and Kobashi K., Hydrolysis of glycyrrhizn to 18-g1ycyrrhety1 monoglucuronide by lysosomal glucuronidase of animal livers. Biochem. Pharmacol, 41, 1025-1029 (1991)
DOI
PUBMED
ScienceOn
|
56 |
Booth A. N., Murry C. W., Jones F. T. and DeEds F. Metabolic fate of rutin and quercetin in the animal body. J. Biot. Chem., 223, 252-257 (1956)
|
57 |
Ghffth L. A. and Barrow A. Metabolism of compounds in germ-free rats. Biochem. J., 130, 1161 (1972)
|
58 |
Kim D. H., Bae E. A., Han M. J., Park H. J., and Choi J. W. Metabolism of kalopanaxsaponi K by human intestinal bacteria and antirheumatoid arthrids acdvity of their metabolites. Biol.Pharm. Bull., 25, 68-71 (2002)
DOI
ScienceOn
|
59 |
Kim D. H., Han S. B., Bae E. A. and Han M. J. Intestinal bacterial metabolism of rutin and its relation to mutagenesis. Arch. Pharm. Res., 19, 41-45 (1996)
DOI
ScienceOn
|
60 |
Baek N. I., Kim D. S., Lee Y. H., Park J. D., Lee C. B. and Kim S. I. Ginsenoside Rh4, a genuine dammarane glycoside from Korean red ginseng, Planta Medica, Volume 62, Issue 1, February 1996, Paees 86-87 Arch. Pharm. Res., 18, 164-168 (1995)
DOI
ScienceOn
|
61 |
Hasegawa H., Sung J. W. and Benno Y. Role of human intestinal Prevotella oris m hydrolyzing ginseng saponins. Planta Med., 63, 436-440 (1997)
DOI
ScienceOn
|
62 |
Karikura M., Miyase T., Tanizawa H., Taniyama T. and Takino Y. Studies on absorpdon, distribution, excretion and metabolism of ginseng sapomns. VI. The decomposition products of gmsenoside Rb2 in the stomach of rats. Chem. Pharm. Bull., 39, 400-404 (1991)
DOI
ScienceOn
|
63 |
Kim D. H., Lee S. W. and Han M. J. Biotransformation of glycyrrhizin to 18B-g1ycyrrhetinic acid glucuronide by Streptococcus LJ-22, a human intestmal bacterium. Biol. Pharm. Bull., 22, 320-322 (1999)
DOI
PUBMED
ScienceOn
|
64 |
Kim D.-H., Jang I.-S., Kim N.-J. and Youn W.-K. Metabolism of poncihn and narmgin by human intestinal bacteha. Yakhak Hoeji, 38, 286-292 (1994)
|
65 |
Nakano N- Kano H., Suzuki H., Nakano N., Yano S. and Kanako M. Enzyme immunoassay of glycyrrhedc acid and glycyrrhizin2. Measurement of plasma glycyrrhetic acid and glycyrrhizin Jpn. Pharmacol. Ther., 8, 4171-4174 (1980) (injapanese)
|
66 |
Pietta P. and Marui P. Improved high performance liquid chromagraphic method for the analysis of ginsenosides in Panax ginseng extracts and products. J. Chromatogr., 356, 212-219 (1986)
DOI
ScienceOn
|
67 |
Kaneoka, M., Akao T. and Kobashi K. Metabolism of ginseng sapomns, gmsenosides, by human intesdnal bacteria. J. Tradit. Med., 11, 241-245 (1998)
|
68 |
Youn W. K., Kim D. H., Kim N. J. and Hong N. D. Biological active components of fruits of Poncirus trifoliata. Yakhak Hoeji, 36, 548-555 (1992)
|
69 |
Kaku T. and Kawashima Y. Isolation and charactehzadon of gmsenoside-Rg2, 20R-prosapogenin, 20(S)-prosapogenin and delta 20(R)-prosapogenm. Chemical studies on sapomns of Panax ginseng C. A. Meyer. Arzneim. Forsch. Drus Res., 30, 936-940 (1980)
|
70 |
Kim D. H., Hong S. W., Kim B. T., Bae E. A., Park H. Y. Han M. J. Biotransformation of glycyrrhizin by human intestinal bacteria and its relation to biological acdvities. Arch. Pharm. Res., 23, 172-177 (2000)
DOI
ScienceOn
|
71 |
Bae E.-A., Park S.-Y., and Kim D.-H., Constitudve b-glucosidases hydrolyzing ginsenoside Rbl and Rb2 from human intestinal bacteria. Biot. Pharm. Bull 23, 1481-1485 (2000)
DOI
ScienceOn
|